Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6353)	11/26/1998 2:42:00 PM
From: Tunica Albuginea	Respond to of 9523

Anthony, Re: "Financial side effects". Remember Posicor. History maybe about to repeat itself IMHO. Posicor was out for only 10 months with great fanfare from the FDA's Renal and Cardiovascular Panel, the same one that approved Viagra. 10 months later, AND 200+ REPORTED DEATHS, It gets yanked off the market June 8,1997. Just to see how dense ( or lethargic may be more appropriate? ) the Europeans are, ONE MONTH AFTER Posicor gets yanked, THEY APPROVE it's introduction,< GG >.So don't pin your hopes in Europe: if Viagra gets yanked/restricted here in the US, it's over. We are now at 130 deaths with Viagra. 133 to be exact ( 3 yesterday in France ). At 4 deaths a week We"ll need 17 weeks or 4 months to get to the 200+ number that did Posicor in ( with it's labeling included, GG ). That's April 1st, Fool's day ( just a coincidence). Probably about the time this Bull Market will be tanking from lack of profits. PFE down to 80? 90? in 2 days? Just in time to cover. Will continue shorting PFE all the way up to $120 were there is a lot of resistance.small amounts initially, bigger as we go higher, Wish me luck, TA PS Don't forget further downside from lawsuits: PFE released Viagra unto millions of impotent men KNOWN to have a high incidence of cardiovascular disease, WITHOUT INCLUDING SUCH PATIENTS in the Viagra trials, Then proceeded to label it "very safe", and now we have 133 Dead people. Bad research. Open and shut case: doctors should use caution prescribing the drug to the kinds of patients excluded from clinical trials, including men who suffered a heart attack, stroke, or life-threatening irregular heart rhythms within the previous six months, as well as patients with a history of cardiac failure or coronary artery disease. Patients with uncontrolled high-blood pressure and those with uncontrolled low-blood pressure also were excluded from clinical trials and should use the drug cautiously. Message 6560808 March 3, 1997 US-FDA Panel recommends Posicor® (mibefradil) for Hypertension and Chronic Stable Angina Pectoris roche.com June 8, 1998 Roche announces voluntary withdrawal of Posicor: The Wall Street Journal, 06/09/1998, Roche Holding Ltd. yesterday took the unusual step of withdrawing its ballyhooed hypertension drug Posicor from the market because of potentially serious interactions between the drug and about 25 other ... roche.com July 2, 1997 Posicor receives European Mutual Recognition Approval roche.com << GGG >>